News & Perspective

Oct 18, 2001

Oct 18, 2001

S pneumoniae resistance to macrolides is now common, CDC says

(CIDRAP News) – Macrolide antibiotics, the mainstay of treatment for community-acquired pneumonia, are encountering increasing resistance from Streptococcus pneumoniae, the most common cause of the disease, according to a report in the Oct 17 issue of the Journal of the American Medical Association.

Oct 01, 2001

Oct 01, 2001

Standard HIV drug used in Africa may spawn resistance to a first-line malaria drug

(CIDRAP News) – Researchers from the University of Maryland School of Medicine have reported laboratory evidence of Plasmodium falciparum cross-resistance between trimethoprim-sulfamethoxazole, one of the standard treatments for HIV patients in Africa, and sulfadoxine-pyrimethamine, the first-line antimalarial drug in parts of Africa.